[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20064808L - Orale matrixformuleringer med licarbazepin - Google Patents

Orale matrixformuleringer med licarbazepin

Info

Publication number
NO20064808L
NO20064808L NO20064808A NO20064808A NO20064808L NO 20064808 L NO20064808 L NO 20064808L NO 20064808 A NO20064808 A NO 20064808A NO 20064808 A NO20064808 A NO 20064808A NO 20064808 L NO20064808 L NO 20064808L
Authority
NO
Norway
Prior art keywords
licarbazepine
matrix formulations
oral matrix
oral
formulations
Prior art date
Application number
NO20064808A
Other languages
English (en)
Inventor
Oskar Kalb
Marie-Christine Wolf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0406379A external-priority patent/GB0406379D0/en
Priority claimed from GB0406738A external-priority patent/GB0406738D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20064808L publication Critical patent/NO20064808L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen vedrører farmasøytiske sammensetninger som innbefatter 10, 11-dihydro10-hydroksy-5H-dibenz[b,f]azepin-5-karboksamid (også referert til som "licarbazepin") som legemiddelsubstans.
NO20064808A 2004-03-22 2006-10-23 Orale matrixformuleringer med licarbazepin NO20064808L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0406379A GB0406379D0 (en) 2004-03-22 2004-03-22 Organic compounds
GB0406738A GB0406738D0 (en) 2004-03-25 2004-03-25 Organic compounds
PCT/EP2005/002988 WO2005092294A1 (en) 2004-03-22 2005-03-21 Oral matrix formulations comprising licarbazepine

Publications (1)

Publication Number Publication Date
NO20064808L true NO20064808L (no) 2006-12-15

Family

ID=34961345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064808A NO20064808L (no) 2004-03-22 2006-10-23 Orale matrixformuleringer med licarbazepin

Country Status (16)

Country Link
US (1) US20070196488A1 (no)
EP (1) EP1732519A1 (no)
JP (1) JP2007529564A (no)
AR (1) AR048318A1 (no)
AU (1) AU2005226910B2 (no)
BR (1) BRPI0509067A (no)
CA (1) CA2558787A1 (no)
EC (1) ECSP066860A (no)
IL (1) IL177826A0 (no)
MA (1) MA28527B1 (no)
MX (1) MXPA06010810A (no)
NO (1) NO20064808L (no)
PE (1) PE20051156A1 (no)
RU (1) RU2006137330A (no)
TW (1) TW200534844A (no)
WO (1) WO2005092294A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
PE20060124A1 (es) * 2004-03-22 2006-03-07 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
EP2384755A1 (en) * 2005-05-06 2011-11-09 Bial-Portela & CA, S.A. Eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
ES2687678T3 (es) 2011-03-08 2018-10-26 Jubilant Life Sciences Limited Procedimiento para la preparación de (S)-(+)-10,11-dihidro-10-hidroxi-5H-dibenzo[b,f]azepina-5-carboxamida y ésteres de la misma mediante reducción enantioselectiva de 10,11-dihidro-10-oxo-5H-dibenzo[b,f]azepina-5-carboxamida
EP2498481A1 (en) 2011-03-09 2012-09-12 Sensirion AG Mobile phone with humidity sensor
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
EP3402488B1 (en) 2015-12-18 2021-10-27 Jubilant Generics Limited Solid oral dosage forms of eslicarbazepine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
IL125244A (en) * 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
CA2485932A1 (en) * 2002-05-31 2003-12-11 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
BR0313230A (pt) * 2002-08-06 2005-07-12 Novartis Ag Uso de carboxamidas para o tratamento de tinido
PE20060124A1 (es) * 2004-03-22 2006-03-07 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina

Also Published As

Publication number Publication date
WO2005092294A1 (en) 2005-10-06
AU2005226910A1 (en) 2005-10-06
MXPA06010810A (es) 2006-12-15
EP1732519A1 (en) 2006-12-20
BRPI0509067A (pt) 2007-08-21
JP2007529564A (ja) 2007-10-25
ECSP066860A (es) 2006-11-24
PE20051156A1 (es) 2006-02-13
AU2005226910B2 (en) 2009-06-04
TW200534844A (en) 2005-11-01
AR048318A1 (es) 2006-04-19
CA2558787A1 (en) 2005-10-06
RU2006137330A (ru) 2008-05-10
MA28527B1 (fr) 2007-04-03
IL177826A0 (en) 2006-12-31
US20070196488A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
NO20064808L (no) Orale matrixformuleringer med licarbazepin
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
IL173571A0 (en) Injectable, oral, or topical sustained release pharmaceutical formulations
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
BRPI0620229A8 (pt) formulação
NO20064783L (no) Opplosningstabeletter med licarbazepin
DK1140031T3 (da) Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
UA87152C2 (ru) Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
NO20085285L (no) 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
TNSN06298A1 (en) Disintegrating tablets comprising licarbazepine
NO20085189L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme
ATE429905T1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
ITTO20020352A0 (it) ,,composizione farmaceutica anti-depressiva contenente estratto di polygala,,.
BRPI0500420A (pt) composição estável para substáncia farmacologicamente ativa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application